AMA Update

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.


All Episodes

AMA Update 88: EvergreenHealth’s Dr. Pratima Sharma shares strategies to support physicians during crisis

AMA CXO Todd Unger talks with Dr. Pratima Sharma, executive medical director of primary care at EvergreenHealth, about how her health system quickly pivoted when it became the first location in the country to identify a COVID positive patient. Dr. Sharma shares strategies for ensuring physician well-being during crisis and how changes her health system made during the pandemic will influence care long term. 

AMA Update 87: Andrea Garcia, JD, MPH, discusses booster rollout, mask studies and this week’s numbers

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the booster roll out, mask studies in schools and the continued politicization of the pandemic.

AMA Update 86: Dr. Sandra Fryhofer shares what physicians need to know about boosters

AMA CXO Todd Unger talks boosters with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices. Learn what physicians need to know about the latest Pfizer booster authorization, including who is eligible, why boosters are needed and what this means for our larger efforts to fight the pandemic. 

AMA Update 85: Andrea Garcia, JD, MPH, shares vaccine updates on boosters and young children

AMA CXO Todd Unger talks with AMA’s Director of Science, Medicine and Public Health, Andrea Garcia, about trending topics related to the pandemic over the past week. Also covering Pfizer’s announcement regarding vaccine effectiveness in 5-11 year olds, the FDA’s decision on booster shots, and a state-by-state look at swings in COVID case count.

AMA Update 84: Andrea Garcia, JD, MPH, discusses Biden’s push for vaccine mandates

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering recently released studies from the CDC, and what the data tells us about the effectiveness of COVID vaccines.

AMA Update 83: Dr. Steven Stack on confronting challenges in Kentucky’s battle against COVID

AMA CXO Todd Unger talks with Dr. Steven Stack, commissioner of the Kentucky Department of Public Health and former AMA president, about how Kentucky is faring in its battle with COVID, including the state’s recent surge in cases and challenges posed by the politicization of health care issues.

AMA Update 82: The FDA’s Dr. John Farley talks about why ivermectin should not be used to prevent or treat COVID

A discussion with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA, about what physicians and patients really need to know about ivermectin.

AMA Update 81: Andrea Garcia, JD, discusses the outlook of the pandemic heading into fall

Discussion with AMA’s Director of Science, Medicine & Public Health, Andrea Garcia, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering booster shots, end-of-summer case numbers and trends, as well as the growing shortage of ICU beds across the U.S.

AMA Update 80: Dr. Sandra Fryhofer discusses boosters and the latest vaccine safety data

Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), a member of ACIP’s COVID-19 Vaccine Workgroup, and chair-elect of the AMA Board of Trustees, shares details from the latest ACIP meeting, including more details on the Pfizer approval, the latest vaccine safety data and the timeline for booster shots.